Inbakicept

Tax included
Inbakicept (ALT-803) is an IL-15 superagonist complex, consisting of IL-15 mutant and IL-15Rα-Fc fusion. Inbakicept magnifies anti-CD20 mAb-mediated NK-cell responses and antibody-dependent cellular cytotoxicity (ADCC). Inbakicept also increases degranulation, IFNγ production in cells.
HY-P99661

Data sheet

Size
Multiple sizes
Reactivity
Interleukin Related
Application
Cancer-programmed cell death
CAS
2135939-52-3